Jose Manuel Correia de Simas - 01 Mar 2022 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President, US Farm Animal Business
Signature
/s/ /s/ Collin G. Smyser, Attorney-in Fact for Jose Manuel Correia de Simas
Issuer symbol
ELAN
Transactions as of
01 Mar 2022
Net transactions value
-$16,583
Form type
4
Filing time
03 Mar 2022, 20:03:24 UTC
Previous filing
02 Jul 2021
Next filing
05 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +5,123 +30% $0.000000 22,352 01 Mar 2022 Direct F1
transaction ELAN Common Stock Tax liability $16,583 -573 -2.6% $28.94 21,779 01 Mar 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option(right to buy) Award $0 +13,614 $0.000000 13,614 01 Mar 2022 Common Stock 13,614 $28.94 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.
F2 Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
F3 Grant of stock options vesting as follows: one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.

Remarks:

Executive Vice President, US Farm Animal Business